TD Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.07K | Hold |
80
| – | – | ﹤0.01% | 537 |
|
|
2025
Q1 | $3.1K | Hold |
80
| – | – | ﹤0.01% | 427 |
|
|
2024
Q4 | $2.71K | Hold |
80
| – | – | ﹤0.01% | 414 |
|
|
2024
Q3 | $3.27K | Hold |
80
| – | – | ﹤0.01% | 375 |
|
|
2024
Q2 | $3.08K | Hold |
80
| – | – | ﹤0.01% | 345 |
|
|
2024
Q1 | $3.43K | Hold |
80
| – | – | ﹤0.01% | 353 |
|
|
2023
Q4 | $2.97K | Hold |
80
| – | – | ﹤0.01% | 350 |
|
|
2023
Q3 | $2.9K | Hold |
80
| – | – | ﹤0.01% | 349 |
|
|
2023
Q2 | $2.85K | Hold |
80
| – | – | ﹤0.01% | 357 |
|
|
2023
Q1 | $2.85K | Hold |
80
| – | – | ﹤0.01% | 352 |
|
|
2022
Q4 | $2.81K | Hold |
80
| – | – | ﹤0.01% | 325 |
|
|
2022
Q3 | $2K | Buy |
+80
| New | +$2K | ﹤0.01% | 322 |
|
|
2022
Q1 | – | Sell |
-80
| Closed | -$4K | – | 202 |
|
|
2021
Q4 | $4K | Hold |
80
| – | – | ﹤0.01% | 320 |
|
|
2021
Q3 | $4K | Hold |
80
| – | – | ﹤0.01% | 303 |
|
|
2021
Q2 | $4K | Hold |
80
| – | – | ﹤0.01% | 292 |
|
|
2021
Q1 | $4K | Hold |
80
| – | – | ﹤0.01% | 268 |
|
|
2020
Q4 | $4K | Hold |
80
| – | – | ﹤0.01% | 234 |
|
|
2020
Q3 | $4K | Hold |
80
| – | – | ﹤0.01% | 204 |
|
|
2020
Q2 | $4K | Hold |
80
| – | – | ﹤0.01% | 204 |
|
|
2020
Q1 | $4K | Hold |
80
| – | – | ﹤0.01% | 189 |
|
|
2019
Q4 | $5K | Hold |
80
| – | – | ﹤0.01% | 209 |
|
|
2019
Q3 | $4K | Hold |
80
| – | – | ﹤0.01% | 216 |
|
|
2019
Q2 | $4K | Buy |
+80
| New | +$4K | ﹤0.01% | 208 |
|